Denis Dufrane is the founder of Novadip Biosciences. Novadip Biosciences has raised $88M in total funding. Latest round: Series B. Based in Leuven, Belgium.
Denis Dufrane is the CEO and Scientific Founder of Novadip Biosciences, a clinical-stage biopharmaceutical company focused on stem cell-based tissue regeneration therapies. He previously held the role of Chief Scientific Officer, where he played a key role in developing the company's technology platform and designing clinical trials. Under his leadership, Novadip Biosciences secured significant funding for its initiatives.
Full founder directory · Investor directory · Company funding database · Fundraising library